Vitamin D analogues: new regulators of cancer cell growth and differentiation
- 30 September 1993
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 3 (9), 1891-1896
- https://doi.org/10.1016/s0960-894x(00)80126-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Vitamin D analogues and psoriasisBritish Journal of Dermatology, 1992
- The effect of 1‐hydroxyvitamin D3 for prolongation of leukemic transformation‐free survival in myelodysplastic syndromesAmerican Journal of Hematology, 1991
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- 1,25(OH) 2 ‐Vitamin D 3 receptors: gene regulation and genetic circuitryThe FASEB Journal, 1988
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas.BMJ, 1985
- Effect of 1 α-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231British Journal of Cancer, 1984
- CLINICAL EVIDENCE FOR 1,25-HYDROXYCHOLECALCIFEROL ACTION IN MYELOFIBROSISThe Lancet, 1984
- 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.Proceedings of the National Academy of Sciences of the United States of America, 1983
- Regulation of Calcium MetabolismAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1976